EBFI Activity Controls Leukemia Sensitivity to Inotuzumab Ozogamicin

被引：0

作者：

Escherich, Carolin S. ^{[1
]}

Li, Zhenhua ^{[2
]}

Barnett, Kelly R. ^{[1
]}

Li, Yizhen ^{[1
]}

Walker, Megan ^{[1
]}

Yang, Wenjian ^{[2
]}

Huang, Xin ^{[1
]}

Yu, Jiyang ^{[1
]}

Stock, Wendy ^{[3
]}

Paietta, Elisabeth ^{[4
]}

Konopleva, Marina ^{[5
]}

Kornblau, Steven M. ^{[6
]}

Litzow, Mark R. ^{[7
]}

Inaba, Hiroto ^{[1
]}

Pui, Ching-Hon ^{[1
]}

Loh, Mignon L. ^{[8
]}

Savic, Daniel ^{[1
]}

Yang, Jun J. ^{[1
]}

机构：

[1] St Jude Childrens Res Hosp, Memphis, TN USA

[2] St Jude Childrens Res Hosp, Dept Pharm & Pharmaceut Sci, Memphis, TN USA

[3] Univ Chicago, Chicago, IL USA

[4] Montefiore Med Ctr, Dept Oncol, Bronx, NY USA

[5] Albert Einstein Coll Med, Bronx, NY USA

[6] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USA

[7] Mayo Clin, Div Hematol, Rochester, MN USA

[8] Univ Washington, Seattle Childrens Hosp, Ben Towne Ctr Childhood Canc Res, Fred Hutch Canc Ctr, Seattle, WA USA

来源：

BLOOD | 2024年 / 144卷

关键词：

D O I：

10.1182/blood-2024-198800

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：830 / 831

页数：2

共 50 条

[1] Inotuzumab ozogamicin in the treatment of acute lymphoblastic leukemia
Dahl, Jenny
Marx, Kayleigh
Jabbour, Elias
EXPERT REVIEW OF HEMATOLOGY, 2016, 9 (04) : 329 - 334
[2] Inotuzumab Ozogamicin for Acute Lymphoblastic Leukemia Reply
Kantarjian, Hagop M.
Vandendries, Erik
Advani, Anjali S.
NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (21): : 2100 - 2101
[3] Inotuzumab ozogamicin for the treatment of acute lymphoblastic leukemia
Tvito, Ariella
Rowe, Jacob M.
EXPERT OPINION ON BIOLOGICAL THERAPY, 2017, 17 (12) : 1557 - 1564
[4] Inotuzumab ozogamicin for the treatment of acute lymphoblastic leukemia
Savoy, J. Michael
Welch, Mary Alma
Nasnas, Patrice E.
Kantarjian, Hagop
Jabbour, Elias
THERAPEUTIC ADVANCES IN HEMATOLOGY, 2018, 9 (12) : 347 - 356
[5] Inotuzumab ozogamicin for the treatment of patients with acute lymphocytic leukemia
Choudhry, A.
O'Brien, S. M.
DRUGS OF TODAY, 2017, 53 (12) : 653 - 665
[6] Inotuzumab ozogamicin
不详
AUSTRALIAN PRESCRIBER, 2019, 42 (04) : 141 - 142
[7] Treatment of adult acute lymphoblastic leukemia with inotuzumab ozogamicin
Paul, Shilpa
Rausch, Caitlin R.
Kantarjian, Hagop
Jabbour, Elias J.
FUTURE ONCOLOGY, 2017, 13 (25) : 2233 - 2242
[8] Inotuzumab Ozogamicin versus Standard Therapy for Acute Lymphoblastic Leukemia
Kantarjian, Hagop M.
DeAngelo, Daniel J.
Stelljes, Matthias
Martinelli, Giovanni
Liedtke, Michaela
Stock, Wendy
Gokbuget, Nicola
O'Brien, Susan
Wang, Kongming
Wang, Tao
Paccagnella, M. Luisa
Sleight, Barbara
Vandendries, Erik
Advani, Anjali S.
NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (08): : 740 - 753
[9] Inotuzumab Ozogamicin Post-Transplant for Acute Lymphocytic Leukemia
Metheny, Leland, III
Sobecks, Ronald
Tomlinson, Benjamin K.
Otegbeye, Folashade
Cooper, Brenda
Majhail, Navneet S.
Caimi, Paolo
Boughan, Kirsten M.
Gallogly, Molly M.
Malek, Ehsan
Galloway, Erin
Hamilton, Betty K.
Kalaycio, Matt
Gerds, Aaron T.
de Lima, Marcos
BLOOD, 2019, 134
[10] Inotuzumab Ozogamicin Post-Transplant for Acute Lymphoblastic Leukemia
Metheny, Leland
Sobecks, Ronald M.
Majhail, Navneet S.
Caimi, Paolo
Otegbeye, Folashade
Cooper, Brenda
Gallogly, Molly
Malek, Ehsan
Tomlinson, Benjamin
Gerds, Aaron T.
Hamilton, Betty K.
de Lime, Marcos
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S122 - S123

← 1 2 3 4 5 →